• Schrodinger EVP and Chief Scientific Officer, Platform, Robert Lorne Abel sold 23,605 common shares at $34 each on November 11, 2026.
• Abel exercised stock options for 21,927 common shares at $17 each, leaving 72,829 stock options.
• His direct common stock holdings stood at 54,219 shares following the transactions, disclosed in a November 12, 2026 filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schrodinger Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001798179-26-000007), on November 12, 2026, and is solely responsible for the information contained therein.